Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate

    NEXT STORY
    AB Science announces that a new independent publication confirms the role of masitinib as a potential therapy in neurodegenerative disorders including Alzheimer’s Disease
    PREV STORY
    Lee’s Pharmaceutical Announces its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Clearance to Start Phase 3 Trial as a First-line Treatment of Extensive-stage Small-Cell Lung Cancer
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Tiba Biotech Appoints Dr. Christian W. Mandl as Chairman of Company’s Scientific Advisory Board

    CAMBRIDGE, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Tiba Biotech, a pre-clinical biotechnology company ...

    author_avatar
    NASDAQ Market News

    Avant Diagnostics Announces Data Presentations at 2016 ASCO Annual Meeting

    SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 19, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. ...

    author_avatar
    NASDAQ Market News

    Aclaris Therapeutics, Inc. Appoints Kevin Scott as Vice President of Sales

    MALVERN, Pa., May 05, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage ...

    author_avatar
    NASDAQ Market News